Showing 861 - 880 results of 7,344 for search 'significantly ((((((larger decrease) OR (teer decrease))) OR (we decrease))) OR (linear decrease))', query time: 0.61s Refine Results
  1. 861

    Image 2_Changes in the gut microbiome due to diarrhea in neonatal Korean indigenous calves.jpeg by Ji-Yeong Ku (20832209)

    Published 2025
    “…However, Proteobacteria increased and Bacteroidetes and Actinobacteria decreased in calves with diarrhea. In addition, calves with diarrhea showed a significant decrease in the diversity of the gut microbiome, especially for anaerobic microorganisms Faecalibacterium prausnitzii, Gemmiger formicilis, and Collinsella aerofaciens. …”
  2. 862

    Image 1_Changes in the gut microbiome due to diarrhea in neonatal Korean indigenous calves.jpeg by Ji-Yeong Ku (20832209)

    Published 2025
    “…However, Proteobacteria increased and Bacteroidetes and Actinobacteria decreased in calves with diarrhea. In addition, calves with diarrhea showed a significant decrease in the diversity of the gut microbiome, especially for anaerobic microorganisms Faecalibacterium prausnitzii, Gemmiger formicilis, and Collinsella aerofaciens. …”
  3. 863

    Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  4. 864

    Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  5. 865

    Summary of measured parameters. by Aaron L. Sayler (19797446)

    Published 2025
    “…Male KO mice also displayed a significant decrease in rearing activity and blood pressure. …”
  6. 866

    Raw data. by Aaron L. Sayler (19797446)

    Published 2025
    “…Male KO mice also displayed a significant decrease in rearing activity and blood pressure. …”
  7. 867

    S1 Graphical abstract - by Aman Goyal (19231397)

    Published 2025
    “…</p><p>Conclusions</p><p>Our analysis showed a significant decrease in mortality from paroxysmal tachycardia since 1999, although there has been a slight increase in recent years. …”
  8. 868

    Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

    Published 2024
    “…Among the letrozole-treated patients, the mean FIB-4 index tended to decline during letrozole treatment; a significant decrease was observed at 18 and 24 months compared with the baseline values (p = 0.044 and p = 0.013). …”
  9. 869

    S1 Data - by Kazuyoshi Ohkawa (836847)

    Published 2024
    “…Among the letrozole-treated patients, the mean FIB-4 index tended to decline during letrozole treatment; a significant decrease was observed at 18 and 24 months compared with the baseline values (p = 0.044 and p = 0.013). …”
  10. 870

    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
  11. 871

    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
  12. 872

    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
  13. 873

    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
  14. 874

    Each subfigure shows a different local size (LS) and context size (CS) configuration, where the reliability of the model across different initializations is measured in R-squared. by Eloy Geenjaar (21533195)

    Published 2025
    “…Moreover, reliability decreases with a larger dimensionality of the context space, likely increasing the dimensions essentially increases the size and thus the number of equivalent solutions of the space. …”
  15. 875
  16. 876

    Distribution of responses to vital signs. by Lisa Thiele (6468056)

    Published 2025
    “…However, barriers to consumer escalation decrease this potential. Interventions to increase consumer knowledge should therefore be accompanied by strategies to minimise barriers.…”
  17. 877

    Survey tool development process. by Lisa Thiele (6468056)

    Published 2025
    “…However, barriers to consumer escalation decrease this potential. Interventions to increase consumer knowledge should therefore be accompanied by strategies to minimise barriers.…”
  18. 878

    Respondent characteristics. by Lisa Thiele (6468056)

    Published 2025
    “…However, barriers to consumer escalation decrease this potential. Interventions to increase consumer knowledge should therefore be accompanied by strategies to minimise barriers.…”
  19. 879

    Sequence of <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

    Published 2024
    “…It was speculated that MeJA significantly decreased expression of <i>DpAP2</i> gene, then the decreasing <i>DpAP2</i> expression significantly inhibited expression of some key enzyme genes such as <i>PSY</i>, <i>PDS</i> and <i>GGPS</i> in carotenoid biosynthesis pathway. …”
  20. 880

    Predicted <i>cis</i>-acting elements in <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

    Published 2024
    “…It was speculated that MeJA significantly decreased expression of <i>DpAP2</i> gene, then the decreasing <i>DpAP2</i> expression significantly inhibited expression of some key enzyme genes such as <i>PSY</i>, <i>PDS</i> and <i>GGPS</i> in carotenoid biosynthesis pathway. …”